YBX1 and cancer: The cellular viability of RASMCs was significantly decreased in shYbx1 samples, while the apoptotic level was significantly increased in shYbx1 samples (Figure 1C,D), suggesting that Ybx1 knockdown repressed the growth and viability of RASMCs, which was consistent with previous results in cancer cells [33].